Montero氏への返信:慢性閉塞性肺疾患患者におけるガバペンチノイド:臨床的有用性と呼吸器系リスクの間
Yuya Kimura1,2, Taisuke Jo3,4, Norihiko Inoue5,6,7
1Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
No abstract available in PubMed .
さらに関連する動画
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
02:34Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease
Published on: May 10, 2024
関連する概念動画
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
